GLP-1 & Weight Management
Liraglutide
Liraglutide — research-grade reference material, supplied in multiple sizes.
- Product Code
- LIR
- Purity
- 99%
- Form
- Lyophilized powder
- Packaging
- 5mg*10vials
Ships from multiple warehouses — typically 2–5 business days to nearby destinations. International orders coordinated per destination.
No prices are published. Available scope, specifications and documentation are confirmed during specification review. Supplied for research and analytical use by qualified organizations — see our Research Use Only policy.
Specification
- Purity specification
- 99%
- Available sizes
- 5mg × 10vials, 10mg × 10vials, 30mg × 10vials
- Storage
- 2–8 °C, away from light and moisture
- MOQ
- On request
Research Applications
- Liraglutide is a long-acting GLP-1 receptor agonist that potentiates glycemic-dependent insulin secretion, serving as a reference compound in incretin and metabolic research.
- Central GLP-1 receptor activation reduces food intake and body weight, making liraglutide a standard tool in rodent and primate metabolic models.
- Used to study GLP-1 receptor-mediated β-cell protection and proliferative signaling in pancreatic islet research.
- Cardiometabolic studies employ liraglutide to investigate GLP-1 receptor effects on cardiovascular function beyond glycemic control.
Send us your specification
Share your sequence, format, packaging and documentation needs. Our team will review scope and next project steps.


